ABL1_HUMAN - dbPTM
ABL1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ABL1_HUMAN
UniProt AC P00519
Protein Name Tyrosine-protein kinase ABL1
Gene Name ABL1
Organism Homo sapiens (Human).
Sequence Length 1130
Subcellular Localization Cytoplasm, cytoskeleton. Nucleus. Mitochondrion. Shuttles between the nucleus and cytoplasm depending on environmental signals. Sequestered into the cytoplasm through interaction with 14-3-3 proteins. Localizes to mitochondria in response to oxidativ
Protein Description Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. In response to oxidative stress, phosphorylates serine/threonine kinase PRKD2 at 'Tyr-717'. [PubMed: 28428613 ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates the caspase CASP9 on 'Tyr-153' and regulates its processing in the apoptotic response to DNA damage. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine-phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E.coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H.pylori, or AnkA (ankyrin repeat-containing protein A) of A.phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Regulates T-cell differentiation in a TBX21-dependent manner. Phosphorylates TBX21 on tyrosine residues leading to an enhancement of its transcriptional activator activity (By similarity]
Protein Sequence MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVSTLLQAPELPTKTRTSRRAAEHRDTTDVPEMPHSKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERLLPKDKKTNLFSALIKKKKKTAPTPPKRSSSFREMDGQPERRGAGEEEGRDISNGALAFTPLDTADPAKSPKPSNGAGVPNGALRESGGSGFRSPHLWKKSSTLTSSRLATGEEEGGGSSSKRFLRSCSASCVPHGAKDTEWRSVTLPRDLQSTGRQFDSSTFGGHKSEKPALPRKRAGENRSDQVTRGTVTPPPRLVKKNEEAADEVFKDIMESSPGSSPPNLTPKPLRRQVTVAPASGLPHKEEAGKGSALGTPAAAEPVTPTSKAGSGAPGGTSKGPAEESRVRRHKHSSESPGRDKGKLSRLKPAPPPPPAASAGKAGGKPSQSPSQEAAGEAVLGAKTKATSLVDAVNSDAAKPSQPGEGLKKPVLPATPKPQSAKPSGTPISPAPVPSTLPSASSALAGDQPSSTAFIPLISTRVSLRKTRQPPERIASGAITKGVVLDSTEALCLAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLENNLRELQICPATAGSGPAATQDFSKLLSSVKEISDIVQR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2 (in isoform 2)Myristoylation-10.12-
16 (in isoform 2)Phosphorylation-34.2323927012
24PhosphorylationLSSSSSCYLEEALQR
CCCCCHHHHHHHHHC
21.0627642862
43PhosphorylationDFEPQGLSEAARWNS
CCCCCCHHHHHHHCC
31.8226074081
50PhosphorylationSEAARWNSKENLLAG
HHHHHHCCCCCCCCC
34.0917192257
59PhosphorylationENLLAGPSENDPNLF
CCCCCCCCCCCCCCE
48.3826074081
70PhosphorylationPNLFVALYDFVASGD
CCCEEEEEEHHHCCC
9.5218691976
75PhosphorylationALYDFVASGDNTLSI
EEEEHHHCCCCEEEE
41.1820068231
79PhosphorylationFVASGDNTLSITKGE
HHHCCCCEEEECCCC
26.9920068231
81PhosphorylationASGDNTLSITKGEKL
HCCCCEEEECCCCEE
26.6124719451
83PhosphorylationGDNTLSITKGEKLRV
CCCEEEECCCCEEEE
29.6220068231
93PhosphorylationEKLRVLGYNHNGEWC
CEEEEEEECCCCCEE
14.7547733
113PhosphorylationNGQGWVPSNYITPVN
CCCCCCCCCCCCCCH
32.4221945579
115PhosphorylationQGWVPSNYITPVNSL
CCCCCCCCCCCCHHH
15.5421945579
117PhosphorylationWVPSNYITPVNSLEK
CCCCCCCCCCHHHCC
15.7221945579
126PhosphorylationVNSLEKHSWYHGPVS
CHHHCCCCCCCCCCC
40.1621945579
128PhosphorylationSLEKHSWYHGPVSRN
HHCCCCCCCCCCCCH
10.4221945579
133PhosphorylationSWYHGPVSRNAAEYL
CCCCCCCCCHHHHHH
23.9721945579
134 (in isoform 2)Phosphorylation-36.7216497976
139PhosphorylationVSRNAAEYLLSSGIN
CCCHHHHHHHHCCCC
14.2823917254
142PhosphorylationNAAEYLLSSGINGSF
HHHHHHHHCCCCCCE
24.75-
154PhosphorylationGSFLVRESESSPGQR
CCEEEEECCCCCCCE
32.0122817900
157PhosphorylationLVRESESSPGQRSIS
EEEECCCCCCCEEEE
29.0628787133
162PhosphorylationESSPGQRSISLRYEG
CCCCCCEEEEEEECC
14.5129496963
164PhosphorylationSPGQRSISLRYEGRV
CCCCEEEEEEECCEE
14.1929496963
167PhosphorylationQRSISLRYEGRVYHY
CEEEEEEECCEEEEE
28.2023917254
172PhosphorylationLRYEGRVYHYRINTA
EEECCEEEEEEEEEC
7.5624732914
174PhosphorylationYEGRVYHYRINTASD
ECCEEEEEEEEECCC
8.7624732914
178PhosphorylationVYHYRINTASDGKLY
EEEEEEEECCCCCEE
25.7628152594
180PhosphorylationHYRINTASDGKLYVS
EEEEEECCCCCEEEC
44.8724732914
185PhosphorylationTASDGKLYVSSESRF
ECCCCCEEECCHHHH
11.1921082442
187PhosphorylationSDGKLYVSSESRFNT
CCCCEEECCHHHHHH
18.1628152594
188PhosphorylationDGKLYVSSESRFNTL
CCCEEECCHHHHHHH
29.5528442448
190PhosphorylationKLYVSSESRFNTLAE
CEEECCHHHHHHHHH
44.0828442448
204 (in isoform 2)Phosphorylation-18.5016497976
215PhosphorylationGLITTLHYPAPKRNK
CCEEECCCCCCCCCC
12.2816912036
224PhosphorylationAPKRNKPTVYGVSPN
CCCCCCCCEEEECCC
28.1529978859
226PhosphorylationKRNKPTVYGVSPNYD
CCCCCCEEEECCCCC
17.8122322096
229PhosphorylationKPTVYGVSPNYDKWE
CCCEEEECCCCCCCC
11.7630849837
232PhosphorylationVYGVSPNYDKWEMER
EEEECCCCCCCCEEE
23.4522322096
243PhosphorylationEMERTDITMKHKLGG
CEEECCCEEEECCCC
23.99-
245 (in isoform 2)Phosphorylation-29.0116497976
251 (in isoform 2)Phosphorylation-18.7512644574
253PhosphorylationHKLGGGQYGEVYEGV
ECCCCCCCCEEECCH
20.6621082442
257PhosphorylationGGQYGEVYEGVWKKY
CCCCCEEECCHHHHE
11.5821082442
264PhosphorylationYEGVWKKYSLTVAVK
ECCHHHHEEEEEEEE
12.7521082442
265PhosphorylationEGVWKKYSLTVAVKT
CCHHHHEEEEEEEEC
26.8328152594
267PhosphorylationVWKKYSLTVAVKTLK
HHHHEEEEEEEECCC
10.6520068231
272 (in isoform 2)Phosphorylation-36.1416497976
274AcetylationTVAVKTLKEDTMEVE
EEEEECCCCCCHHHH
59.7919815429
276 (in isoform 2)Phosphorylation-50.1716497976
283 (in isoform 2)Phosphorylation-8.1612644574
285UbiquitinationMEVEEFLKEAAVMKE
HHHHHHHHHHHHHHH
51.10-
306PhosphorylationVQLLGVCTREPPFYI
HHHHCEECCCCCEEE
35.3446157193
312PhosphorylationCTREPPFYIITEFMT
ECCCCCEEEEEEHHH
9.3718775312
320PhosphorylationIITEFMTYGNLLDYL
EEEEHHHHHHHHHHH
7.709845501
389PhosphorylationFGLSRLMTGDTYTAH
HCCCHHCCCCCEECC
36.1821945579
392PhosphorylationSRLMTGDTYTAHAGA
CHHCCCCCEECCCCC
24.9021945579
393DephosphorylationRLMTGDTYTAHAGAK
HHCCCCCEECCCCCC
13.4811163214
393PhosphorylationRLMTGDTYTAHAGAK
HHCCCCCEECCCCCC
13.4822322096
394PhosphorylationLMTGDTYTAHAGAKF
HCCCCCEECCCCCCC
17.6621945579
400UbiquitinationYTAHAGAKFPIKWTA
EECCCCCCCCCEECC
51.24-
406PhosphorylationAKFPIKWTAPESLAY
CCCCCEECCCHHHHC
27.60-
412 (in isoform 2)Phosphorylation-18.3515592455
413PhosphorylationTAPESLAYNKFSIKS
CCCHHHHCCCCCCCC
24.9516464493
417PhosphorylationSLAYNKFSIKSDVWA
HHHCCCCCCCCHHHH
30.62-
446PhosphorylationPYPGIDLSQVYELLE
CCCCCCHHHHHHHHH
17.538668151
456PhosphorylationYELLEKDYRMERPEG
HHHHHHHHCCCCCCC
23.957347443
469PhosphorylationEGCPEKVYELMRACW
CCCCHHHHHHHHHHH
17.8912522270
488 (in isoform 2)Phosphorylation-38.7116464493
512UbiquitinationEVEKELGKQGVRGAV
HHHHHHHHCCHHHHH
57.41-
532PhosphorylationAPELPTKTRTSRRAA
CCCCCCCCCHHHHHH
41.48-
535PhosphorylationLPTKTRTSRRAAEHR
CCCCCCHHHHHHHCC
19.2420810815
545PhosphorylationAAEHRDTTDVPEMPH
HHHCCCCCCCCCCCC
39.0128555341
559PhosphorylationHSKGQGESDPLDHEP
CCCCCCCCCCCCCCC
51.8823927012
569PhosphorylationLDHEPAVSPLLPRKE
CCCCCCCCCCCCCHH
16.3729255136
597PhosphorylationLLPKDKKTNLFSALI
CCCCCCCCCHHHHHH
42.7869214187
601PhosphorylationDKKTNLFSALIKKKK
CCCCCHHHHHHHHHC
25.9046157163
610PhosphorylationLIKKKKKTAPTPPKR
HHHHHCCCCCCCCCC
46.9137816903
613PhosphorylationKKKKTAPTPPKRSSS
HHCCCCCCCCCCCCC
50.1617192257
618PhosphorylationAPTPPKRSSSFREMD
CCCCCCCCCCHHHCC
36.1423401153
619PhosphorylationPTPPKRSSSFREMDG
CCCCCCCCCHHHCCC
37.2123401153
620PhosphorylationTPPKRSSSFREMDGQ
CCCCCCCCHHHCCCC
29.5725159151
642PhosphorylationEEEGRDISNGALAFT
CCCCCCCCCCCEEEE
33.2424667141
649PhosphorylationSNGALAFTPLDTADP
CCCCEEEEECCCCCC
19.8280535829
653PhosphorylationLAFTPLDTADPAKSP
EEEEECCCCCCCCCC
40.4125850435
659PhosphorylationDTADPAKSPKPSNGA
CCCCCCCCCCCCCCC
40.0230631047
663PhosphorylationPAKSPKPSNGAGVPN
CCCCCCCCCCCCCCC
54.7622199227
676PhosphorylationPNGALRESGGSGFRS
CCCCCCCCCCCCCCC
41.8625159151
679PhosphorylationALRESGGSGFRSPHL
CCCCCCCCCCCCCCC
37.9823401153
683PhosphorylationSGGSGFRSPHLWKKS
CCCCCCCCCCCCCCC
17.8923401153
689MethylationRSPHLWKKSSTLTSS
CCCCCCCCCCCCCCC
37.75-
690PhosphorylationSPHLWKKSSTLTSSR
CCCCCCCCCCCCCCC
25.4830576142
691PhosphorylationPHLWKKSSTLTSSRL
CCCCCCCCCCCCCCC
35.9926074081
692PhosphorylationHLWKKSSTLTSSRLA
CCCCCCCCCCCCCCC
40.9426074081
694PhosphorylationWKKSSTLTSSRLATG
CCCCCCCCCCCCCCC
25.4123312004
695PhosphorylationKKSSTLTSSRLATGE
CCCCCCCCCCCCCCC
19.3023186163
696PhosphorylationKSSTLTSSRLATGEE
CCCCCCCCCCCCCCC
26.5223312004
700PhosphorylationLTSSRLATGEEEGGG
CCCCCCCCCCCCCCC
50.1212300595
708PhosphorylationGEEEGGGSSSKRFLR
CCCCCCCCCHHHHHH
34.4121815630
709PhosphorylationEEEGGGSSSKRFLRS
CCCCCCCCHHHHHHH
43.0612300613
710PhosphorylationEEGGGSSSKRFLRSC
CCCCCCCHHHHHHHC
29.5530576142
711AcetylationEGGGSSSKRFLRSCS
CCCCCCHHHHHHHCC
49.4716648821
716PhosphorylationSSKRFLRSCSASCVP
CHHHHHHHCCCCCCC
17.9923927012
718PhosphorylationKRFLRSCSASCVPHG
HHHHHHCCCCCCCCC
25.1823401153
720PhosphorylationFLRSCSASCVPHGAK
HHHHCCCCCCCCCCC
10.1923927012
729PhosphorylationVPHGAKDTEWRSVTL
CCCCCCCCCCEEEEC
36.4223312004
730AcetylationPHGAKDTEWRSVTLP
CCCCCCCCCEEEECC
51.5316648821
730 (in isoform 2)Acetylation-51.53-
733PhosphorylationAKDTEWRSVTLPRDL
CCCCCCEEEECCHHH
22.1123403867
735PhosphorylationDTEWRSVTLPRDLQS
CCCCEEEECCHHHHH
32.0919643477
743PhosphorylationLPRDLQSTGRQFDSS
CCHHHHHHCCCCCCC
24.3524719451
751PhosphorylationGRQFDSSTFGGHKSE
CCCCCCCCCCCCCCC
30.1923917254
754 (in isoform 2)Phosphorylation-22.3615696159
759AcetylationFGGHKSEKPALPRKR
CCCCCCCCCCCCCCC
42.567822139
779PhosphorylationSDQVTRGTVTPPPRL
CCCCCCCCCCCCCCH
20.2323403867
781PhosphorylationQVTRGTVTPPPRLVK
CCCCCCCCCCCCHHC
29.8917192257
804PhosphorylationVFKDIMESSPGSSPP
HHHHHHHHCCCCCCC
25.1825159151
805PhosphorylationFKDIMESSPGSSPPN
HHHHHHHCCCCCCCC
21.7025159151
808PhosphorylationIMESSPGSSPPNLTP
HHHHCCCCCCCCCCC
42.9529255136
809PhosphorylationMESSPGSSPPNLTPK
HHHCCCCCCCCCCCC
50.7429255136
814PhosphorylationGSSPPNLTPKPLRRQ
CCCCCCCCCCCCCCC
35.5929255136
823PhosphorylationKPLRRQVTVAPASGL
CCCCCCEEEEECCCC
11.5626074081
828PhosphorylationQVTVAPASGLPHKEE
CEEEEECCCCCCHHH
39.5418691976
840PhosphorylationKEEAGKGSALGTPAA
HHHCCCCCCCCCCCC
24.6529396449
844PhosphorylationGKGSALGTPAAAEPV
CCCCCCCCCCCCCCC
15.5925159151
852PhosphorylationPAAAEPVTPTSKAGS
CCCCCCCCCCCCCCC
31.4030266825
854PhosphorylationAAEPVTPTSKAGSGA
CCCCCCCCCCCCCCC
33.2329255136
855O-linked_GlycosylationAEPVTPTSKAGSGAP
CCCCCCCCCCCCCCC
23.0130059200
855PhosphorylationAEPVTPTSKAGSGAP
CCCCCCCCCCCCCCC
23.0130266825
859PhosphorylationTPTSKAGSGAPGGTS
CCCCCCCCCCCCCCC
36.3282313401
884PhosphorylationRHKHSSESPGRDKGK
HCCCCCCCCCCCCCC
34.3023099
915PhosphorylationGKAGGKPSQSPSQEA
CCCCCCCCCCCCHHH
46.9422167270
917PhosphorylationAGGKPSQSPSQEAAG
CCCCCCCCCCHHHHH
30.7522167270
919PhosphorylationGKPSQSPSQEAAGEA
CCCCCCCCHHHHHHH
45.9922167270
935PhosphorylationLGAKTKATSLVDAVN
HCCCHHHHHHHHHHC
24.93-
936PhosphorylationGAKTKATSLVDAVNS
CCCHHHHHHHHHHCC
31.1217192257
943PhosphorylationSLVDAVNSDAAKPSQ
HHHHHHCCCCCCCCC
23.25-
949PhosphorylationNSDAAKPSQPGEGLK
CCCCCCCCCCCCCCC
48.5821406692
963PhosphorylationKKPVLPATPKPQSAK
CCCCCCCCCCCCCCC
29.8825159151
968PhosphorylationPATPKPQSAKPSGTP
CCCCCCCCCCCCCCC
46.9517081983
977PhosphorylationKPSGTPISPAPVPST
CCCCCCCCCCCCCCC
19.0617192257
989PhosphorylationPSTLPSASSALAGDQ
CCCCCCCCHHHCCCC
22.0818691976
1011PhosphorylationPLISTRVSLRKTRQP
HHEECHHCCCCCCCC
21.1125627689
1044PhosphorylationEALCLAISRNSEQMA
HHHHHHHHCCCHHHH
21.5824719451
1064PhosphorylationLEAGKNLYTFCVSYV
HHHHCHHHHHHHHHH
13.7345559739
1070PhosphorylationLYTFCVSYVDSIQQM
HHHHHHHHHHHHHHH
6.4669101443
1103PhosphorylationELQICPATAGSGPAA
HCEECHHCCCCCCCH
19.3825262027
1106PhosphorylationICPATAGSGPAATQD
ECHHCCCCCCCHHHH
38.8662175385
1111PhosphorylationAGSGPAATQDFSKLL
CCCCCCHHHHHHHHH
30.6723917254
1115PhosphorylationPAATQDFSKLLSSVK
CCHHHHHHHHHHHHH
30.5925262027
1119PhosphorylationQDFSKLLSSVKEISD
HHHHHHHHHHHHHHH
43.4524719451
1125PhosphorylationLSSVKEISDIVQR--
HHHHHHHHHHHHC--
23.5224719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
70YPhosphorylationKinaseFYNP06241
PSP
70YPhosphorylationKinaseABL1P00519
GPS
70YPhosphorylationKinaseHCKP08631
PSP
70YPhosphorylationKinaseLYNP07948
PSP
89YPhosphorylationKinaseHCKP08631
GPS
115YPhosphorylationKinaseLYNP07948
PSP
115YPhosphorylationKinaseFYNP06241
PSP
115YPhosphorylationKinaseHCKP08631
PSP
128YPhosphorylationKinaseFYNP06241
PSP
128YPhosphorylationKinaseHCKP08631
PSP
128YPhosphorylationKinaseLYNP07948
PSP
139YPhosphorylationKinaseLYNP07948
PSP
139YPhosphorylationKinaseHCKP08631
PSP
139YPhosphorylationKinaseFYNP06241
PSP
172YPhosphorylationKinaseHCKP08631
PSP
172YPhosphorylationKinaseLYNP07948
PSP
172YPhosphorylationKinaseFYNP06241
PSP
185YPhosphorylationKinaseLYNP07948
PSP
185YPhosphorylationKinaseHCKP08631
PSP
185YPhosphorylationKinaseFYNP06241
PSP
197TPhosphorylationKinaseLATS2Q9NRM7
PSP
215YPhosphorylationKinaseFYNP06241
PSP
215YPhosphorylationKinaseHCKP08631
PSP
215YPhosphorylationKinaseLYNP07948
PSP
226YPhosphorylationKinaseHCKP08631
PSP
226YPhosphorylationKinaseFYNP06241
PSP
226YPhosphorylationKinaseLYNP07948
PSP
226YPhosphorylationKinaseABL1P00519
GPS
232YPhosphorylationKinaseBCR-ABL1A9UF07
PSP
245YPhosphorylationKinasePDGFRBP09619
GPS
245YPhosphorylationKinaseHCKP08631
GPS
253YPhosphorylationKinaseBCR-ABL1A9UF07
PSP
257YPhosphorylationKinaseBCR-ABL1A9UF07
PSP
393YPhosphorylationKinaseHCKP08631
PSP
393YPhosphorylationKinaseSRC-TYPE TYR-KINASES-Uniprot
393YPhosphorylationKinaseSRC-FAMILY-GPS
393YPhosphorylationKinaseABL-FAMILY-GPS
393YPhosphorylationKinaseABL1P00519
PhosphoELM
393YPhosphorylationKinaseFYNP06241
PSP
393YPhosphorylationKinaseLYNP07948
PSP
412YPhosphorylationKinaseABL1P00519
GPS
412YPhosphorylationKinasePDGFRBP09619
GPS
412YPhosphorylationKinaseABL-FAMILY-GPS
446SPhosphorylationKinaseATMQ13315
PhosphoELM
446SPhosphorylationKinaseATMQ62388
PSP
488YPhosphorylationKinaseSRCP12931
PSP
618SPhosphorylationKinasePAK2Q13177
Uniprot
619SPhosphorylationKinasePAK2Q13177
Uniprot
735TPhosphorylationKinaseMAP3K8P41279
GPS
735TPhosphorylationKinaseCLK1P49759
PSP
735TPhosphorylationKinaseSTK3Q13188
GPS
735TPhosphorylationKinaseSTK4Q13043
GPS
735TPhosphorylationKinaseTTKP33981
PSP
735TPhosphorylationKinaseCLK4Q9HAZ1
PSP
-KUbiquitinationE3 ubiquitin ligaseFBXL5Q9UKA1
PMID:24658274
-KUbiquitinationE3 ubiquitin ligaseCBLP22681
PMID:12475393

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
446SPhosphorylation

-
569SPhosphorylation

17081983
618SPhosphorylation

18161990
619SPhosphorylation

18161990
711KAcetylation

16648821
735TPhosphorylation

15696159

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ABL1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PTN6_HUMANPTPN6physical
8692915
RB_HUMANRB1physical
9071815
BRCA1_HUMANBRCA1physical
12024016
BCR_HUMANBCRphysical
1712671
ABL1_HUMANABL1physical
12654250
P85A_HUMANPIK3R1physical
8294442
RAD51_HUMANRAD51physical
10212258
ABI2_HUMANABI2physical
12569093
CREB1_MOUSECreb1physical
7565761
ABL2_HUMANABL2physical
12569093
ATM_HUMANATMphysical
10212258
CREB1_HUMANCREB1physical
7565761
CRKL_HUMANCRKLphysical
8978305
CRKL_HUMANCRKLphysical
7926767
JAK1_HUMANJAK1physical
9774693
GPX1_HUMANGPX1physical
12893824
CATA_HUMANCATphysical
12777400
ABI1_HUMANABI1physical
9010225
P53_HUMANTP53physical
10629029
SHIP2_HUMANINPPL1physical
10194451
SHC1_HUMANSHC1physical
8112292
BCR_HUMANBCRphysical
8112292
PRKDC_HUMANPRKDCphysical
9312071
P73_HUMANTP73physical
10391251
P73_HUMANTP73physical
10391250
RFX1_HUMANRFX1physical
9583676
RAD9A_HUMANRAD9Aphysical
11971963
ATM_HUMANATMphysical
11375976
TERF1_HUMANTERF1physical
11375976
HCK_HUMANHCKphysical
9407116
GRB2_HUMANGRB2physical
9407116
DOK1_HUMANDOK1physical
9008161
VAV_HUMANVAV1physical
11790798
MDM2_HUMANMDM2physical
12110584
MTOR_HUMANMTORphysical
10753870
ZDH16_HUMANZDHHC16physical
12021275
SPTA1_HUMANSPTA1physical
9593709
SPTN1_HUMANSPTAN1physical
9593709
EVL_HUMANEVLphysical
10945997
CASL_HUMANNEDD9physical
8668148
SRBS2_HUMANSORBS2physical
9211900
TUB_HUMANTUBphysical
10455176
GRB10_HUMANGRB10physical
9006901
RYBP_HUMANRYBPphysical
8943360
PHAG1_HUMANPAG1physical
9334312
ATM_HUMANATMphysical
9168117
CBL_HUMANCBLphysical
11494134
NTRK1_HUMANNTRK1physical
10708759
PLCG1_HUMANPLCG1physical
10708759
BCAR1_HUMANBCAR1physical
7780740
MICA1_HUMANMICAL1physical
11827972
SHD_HUMANSHDphysical
9315092
SHE_HUMANSHEphysical
9315092
NCK1_HUMANNCK1physical
7926767
GRB2_HUMANGRB2physical
7926767
EPHB2_HUMANEPHB2physical
11494128
EPHA3_HUMANEPHA3physical
11494128
SRC_HUMANSRCphysical
11494128
NCOA3_HUMANNCOA3physical
18765637
TOPB1_HUMANTOPBP1physical
15961388
HS90A_HUMANHSP90AA1physical
15937340
HSP74_HUMANHSPA4physical
15937340
IKBA_HUMANNFKBIAphysical
12167702
PRKN_HUMANPARK2physical
20823226
STK4_HUMANSTK4physical
21715626
ATR_HUMANATRphysical
20798688
BAG1_HUMANBAG1physical
20675402
PRKN_HUMANPARK2physical
21209200
PCNA_HUMANPCNAphysical
22238610
PSA7_HUMANPSMA7physical
16678104
PSA4_HUMANPSMA4physical
16678104
WRIP1_HUMANWRNIP1physical
17888034
NCK1_HUMANNCK1physical
10372803
CBL_HUMANCBLphysical
16955467
CRKL_HUMANCRKLphysical
16955467
GRB2_HUMANGRB2physical
16955467
GRB2_HUMANGRB2physical
19823681
DOK1_HUMANDOK1physical
19823681
CBL_HUMANCBLphysical
10829062
SRBS1_HUMANSORBS1physical
19891780
GRB2_HUMANGRB2physical
14725908
CBL_HUMANCBLphysical
9174058
HUWE1_HUMANHUWE1physical
7968380
MDM4_HUMANMDM4physical
19075013
CBL_HUMANCBLphysical
8626543
CBL_HUMANCBLphysical
9195915
CBL_HUMANCBLphysical
15556646
DDB1_MOUSEDdb1physical
12107171
P85B_HUMANPIK3R2physical
19380743
SHIP2_HUMANINPPL1physical
19380743
SHC1_HUMANSHC1physical
19380743
GRB2_HUMANGRB2physical
19380743
P85A_HUMANPIK3R1physical
19380743
AP2M1_HUMANAP2M1physical
19380743
CBL_HUMANCBLphysical
19380743
UBS3B_HUMANUBASH3Bphysical
19380743
EPS15_HUMANEPS15physical
19380743
CRK_HUMANCRKphysical
19380743
AP2B1_HUMANAP2B1physical
19380743
BMP2K_HUMANBMP2Kphysical
19380743
REPS1_HUMANREPS1physical
19380743
STON2_HUMANSTON2physical
19380743
CBLB_HUMANCBLBphysical
19380743
AP2A1_HUMANAP2A1physical
19380743
TAU_HUMANMAPTphysical
18070606
CRK_HUMANCRKphysical
18835194
CRKL_HUMANCRKLphysical
18835194
PFD4_HUMANPFDN4physical
22939629
PDE4D_HUMANPDE4Dphysical
10571082
PRDX1_HUMANPRDX1physical
17352427
BRCA1_HUMANBRCA1physical
17352427
EGFR_HUMANEGFRphysical
16273093
ERBB2_HUMANERBB2physical
16273093
ERBB3_HUMANERBB3physical
16273093
ERBB4_HUMANERBB4physical
16273093
WASF1_HUMANWASF1physical
10970852
MUC1_HUMANMUC1physical
16888623
DOK2_HUMANDOK2physical
9478921
CDN1B_HUMANCDKN1Bphysical
17254966
DOK1_HUMANDOK1physical
9822717
HS90A_HUMANHSP90AA1physical
16723087
TEBP_HUMANPTGES3physical
16723087
HSP74_HUMANHSPA4physical
16723087
CH60_HUMANHSPD1physical
16723087
CTNB1_HUMANCTNNB1physical
23950177
DOK1_HUMANDOK1physical
10688886
UBP7_HUMANUSP7physical
24317448
LATS2_HUMANLATS2physical
23852372
SPR2A_HUMANSPRR2Aphysical
18155796
CASP9_HUMANCASP9physical
15657060
1433G_HUMANYWHAGphysical
15696159
1433B_HUMANYWHABphysical
15696159
1433E_HUMANYWHAEphysical
15696159
1433Z_HUMANYWHAZphysical
15696159
1433F_HUMANYWHAHphysical
15696159
1433T_HUMANYWHAQphysical
15696159
CRK_HUMANCRKphysical
15696159
YAP1_HUMANYAP1physical
18280240
ABI1_HUMANABI1physical
18328268
ABL2_HUMANABL2physical
15735735
JUN_HUMANJUNphysical
18619508
CRK_HUMANCRKphysical
18619508
FOS_HUMANFOSphysical
18619508
RB_HUMANRB1physical
7828850
CCND2_HUMANCCND2physical
7828850
CRK_HUMANCRKphysical
8194526
GRB2_HUMANGRB2physical
8194526
TAU_HUMANMAPTphysical
16014719
CDON_HUMANCDONphysical
19470755
CDON_RATCdonphysical
19470755
MBP_HUMANMBPphysical
19470755
JIP4_HUMANSPAG9physical
19470755
MSH5_HUMANMSH5physical
16397227
ABL1_HUMANABL1physical
16397227
MSH5_HUMANMSH5physical
19442657
MSH5_MOUSEMsh5physical
19442657
RAD51_HUMANRAD51physical
19427856
MAVS_HUMANMAVSphysical
19914245
RPGF1_HUMANRAPGEF1physical
16443220
KPCZ_HUMANPRKCZphysical
16631755
B2CL1_HUMANBCL2L1physical
16631755
CKAP4_HUMANCKAP4physical
25852190
DDX5_HUMANDDX5physical
25852190
DRG1_HUMANDRG1physical
25852190
EF1G_HUMANEEF1Gphysical
25852190
EIF2A_HUMANEIF2Aphysical
25852190
EWS_HUMANEWSR1physical
25852190
FUS_HUMANFUSphysical
25852190
HNRPM_HUMANHNRNPMphysical
25852190
CH10_HUMANHSPE1physical
25852190
ILF3_HUMANILF3physical
25852190
LRC59_HUMANLRRC59physical
25852190
RL37_HUMANRPL37physical
25852190
RLA1_HUMANRPLP1physical
25852190
RS21_HUMANRPS21physical
25852190
TCP4_HUMANSUB1physical
25852190
XRCC6_HUMANXRCC6physical
25852190
1433B_HUMANYWHABphysical
25852190
1433E_HUMANYWHAEphysical
25852190
1433G_HUMANYWHAGphysical
25852190
1433F_HUMANYWHAHphysical
25852190
1433T_HUMANYWHAQphysical
25852190
1433Z_HUMANYWHAZphysical
25852190
ABI2_HUMANABI2physical
17101133
SHB_HUMANSHBphysical
17112510
MDM2_HUMANMDM2physical
25624478
SYLC_HUMANLARSphysical
26344197
NAA25_HUMANNAA25physical
26344197
SYNC_HUMANNARSphysical
26344197
PAK4_HUMANPAK4physical
26344197
PPM1B_HUMANPPM1Bphysical
26344197
CRK_HUMANCRKphysical
9747873
HIPK2_HUMANHIPK2physical
25944899
CDN1A_HUMANCDKN1Aphysical
23007395
KS6B1_HUMANRPS6KB1genetic
28319113
CHIP_HUMANSTUB1physical
28128329
EMD_HUMANEMDphysical
19789182
LAP2A_HUMANTMPOphysical
19789182
LAP2B_HUMANTMPOphysical
19789182
ABI2_HUMANABI2physical
27229929
APC15_HUMANANAPC15physical
27229929
DVL2_HUMANDVL2physical
27229929
PKHA4_HUMANPLEKHA4physical
27229929
RAD51_HUMANRAD51physical
21653319
CRK_HUMANCRKphysical
12097319

Drug and Disease Associations
Kegg Disease
H00001 Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
H00004 Chronic myeloid leukemia (CML)
OMIM Disease
608232Leukemia, chronic myeloid (CML)
Kegg Drug
D01441 Imatinib mesilate (JAN); Imatinib mesylate (USAN); Gleevec (TN); Glivec (TN)
D03252 Bosutinib (USAN)
D03658 Dasatinib (INN)
D06413 Nilotinib hydrochloride hydrate (JAN); Tasigna (TN)
D06414 Dasatinib hydrate (JAN); Dasatinib (USAN); Sprycel (TN)
D08066 Imatinib (INN); Glamox (TN)
D08279 Tozasertib (USAN)
D08344 Tozasertib lactate (USAN); MK-0457
D08953 Nilotinib (USAN/INN)
D09664 Saracatinib (USAN/INN)
D09665 Saracatinib difumarate (USAN)
D09728 Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN)
D09950 Ponatinib (USAN/INN)
D09951 Ponatinib hydrochloride (USAN); Iclusig (TN)
D10202 Bafetinib (USAN)
D10334 Rebastinib (USAN)
D10399 Rebastinib Tosylate (USAN)
DrugBank
DB00171Adenosine triphosphate
DB06616Bosutinib
DB01254Dasatinib
DB00619Imatinib
DB04868Nilotinib
DB08901Ponatinib
DB08896Regorafenib
Regulatory Network of ABL1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"c-Abl acetylation by histone acetyltransferases regulates itsnuclear-cytoplasmic localization.";
di Bari M.G., Ciuffini L., Mingardi M., Testi R., Soddu S., Barila D.;
EMBO Rep. 7:727-733(2006).
Cited for: ACETYLATION AT LYS-711, AND SUBCELLULAR LOCATION.
Phosphorylation
ReferencePubMed
"Organization of the SH3-SH2 unit in active and inactive forms of thec-Abl tyrosine kinase.";
Nagar B., Hantschel O., Seeliger M., Davies J.M., Weis W.I.,Superti-Furga G., Kuriyan J.;
Mol. Cell 21:787-798(2006).
Cited for: X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS) OF 38-512, MASS SPECTROMETRY,MYRISTOYLATION OF N-TERMINUS (ISOFORM IB), PHOSPHORYLATION AT SER-50,AUTOINHIBITION MECHANISM, AND ENZYME REGULATION.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-569, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-392; TYR-393 ANDSER-569, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-805; SER-809; THR-852AND SER-855, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569; THR-844; THR-852AND SER-917, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; TYR-185; TYR-393;SER-569; THR-613; SER-620; SER-659; SER-683; SER-718; THR-781;SER-805; SER-809; THR-814; THR-844; THR-852; SER-917; SER-919; SER-936AND SER-977, AND MASS SPECTROMETRY.
"Phosphorylation of c-Abl by protein kinase Pak2 regulatesdifferential binding of ABI2 and CRK.";
Jung J.H., Pendergast A.M., Zipfel P.A., Traugh J.A.;
Biochemistry 47:1094-1104(2008).
Cited for: PHOSPHORYLATION AT SER-618 AND SER-619, AND INTERACTION WITH ABI2 ANDCRK.
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry.";
Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.;
Mol. Cell. Proteomics 6:537-547(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569; SER-683; SER-805;SER-809 AND SER-949, AND MASS SPECTROMETRY.
"JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting ofc-Abl in the apoptotic response to DNA damage.";
Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
Nat. Cell Biol. 7:278-285(2005).
Cited for: INTERACTION WITH YWHAB; YWHAE; YWHAG; YWHAH; SFN AND YWHAZ,PHOSPHORYLATION AT THR-735, MASS SPECTROMETRY, SUBCELLULAR LOCATION,AND MUTAGENESIS OF THR-735.
"Profiling of tyrosine phosphorylation pathways in human cells usingmass spectrometry.";
Salomon A.R., Ficarro S.B., Brill L.M., Brinker A., Phung Q.T.,Ericson C., Sauer K., Brock A., Horn D.M., Schultz P.G., Peters E.C.;
Proc. Natl. Acad. Sci. U.S.A. 100:443-448(2003).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185; TYR-226; TYR-253;TYR-257; TYR-264; TYR-393; THR-394 AND TYR-469, AND MASS SPECTROMETRY.
"Tyrosine phosphorylation in the SH3 domain disrupts negativeregulatory interactions within the c-Abl kinase core.";
Chen S., O'Reilly L.P., Smithgall T.E., Engen J.R.;
J. Mol. Biol. 383:414-423(2008).
Cited for: PHOSPHORYLATION AT TYR-70, AND INTERACTION WITH ABI1.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185, AND MASSSPECTROMETRY.

TOP